Screener
Tarsus Pharmaceuticals, Inc. TARS Total costs & expenses
Total costs & expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of sales | 12,113 | 6,237 | 21,509 | 11,448 |
| Research and development | 31,010 | 15,594 | 53,361 | 30,003 |
| Selling, general and administrative | 150,697 | 103,013 | 287,126 | 188,008 |
| Total operating expenses | 193,820 | 124,844 | 361,996 | 229,459 |
| Loss from operations before other income (expense) | (19,908) | (22,184) | (26,030) | (48,464) |
| Other income (expense): | ||||
| Interest income | 3,698 | 4,229 | 7,420 | 7,683 |
| Interest expense | (2,156) | (2,240) | (4,284) | (4,453) |
Item 1. Financial Statements
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s total costs & expenses?
- Tarsus Pharmaceuticals, Inc. (TARS) reported total costs & expenses of $193.82M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s total costs & expenses changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s total costs & expenses increased by 55.2% year-over-year, from $124.84M to $193.82M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s total costs & expenses?
- Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s total costs & expenses has grown at a 80.7% compound annual growth rate (CAGR), from $88.53M to $522.33M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to support its business activities during a specific period. It encompasses research and development investments, selling, general, and administrative expenses, and other operational outlays required to sustain commercial operations. Monitoring this figure helps investors assess the company's overall cost structure and operational efficiency relative to its revenue generation.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude